The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete.
The reader should not assume that the information is accurate and complete.

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 13F

FORM 13F INFORMATION TABLE
OMB APPROVAL
OMB Number: 3235-0006
Estimated average burden
hours per response: 23.8
COLUMN 1 COLUMN 2 COLUMN 3 COLUMN 4 COLUMN 5 COLUMN 6 COLUMN 7 COLUMN 8
VALUE SHRS OR SH/ PUT/ INVESTMENT OTHER VOTING AUTHORITY
NAME OF ISSUER TITLE OF CLASS CUSIP (x$1000) PRN AMT PRN CALL DISCRETION MANAGER SOLE SHARED NONE
Aratana Therapeutics Inc. Common 03874P101 83,105 4,351,048 SH   SOLE   4,351,048 0 0
AVEO Pharmaceuticals, Inc. Common 053588109 2,511 1,372,118 SH   SOLE   1,372,118 0 0
Conatus Pharmaceuticals, Inc. Common 20600T108 7,689 1,192,080 SH   SOLE   1,192,080 0 0
EnteroMedics, Inc. Common 29365M208 3,406 1,669,753 SH   SOLE   1,669,753 0 0
EpiZyme, Inc. Common 29428V104 59,914 2,880,485 SH   SOLE   2,880,485 0 0
Kalobios Pharmaceuticals, Inc. Common 48344T100 11,638 2,632,928 SH   SOLE   2,632,928 0 0
MacroGenics, Inc. Common 556099109 48,852 1,780,955 SH   SOLE   1,780,955 0 0
Pacira Pharmaceuticals, Inc. Common 695127100 5,749 100,000 SH   SOLE   100,000 0 0
PharmAthene, Inc. Common 71714G102 11,807 6,347,614 SH   SOLE   6,347,614 0 0
Portola Pharmaceuticals, Inc. Common 737010108 62,865 2,441,344 SH   SOLE   2,441,344 0 0
Sangamo biosciences, Inc. Common 800677106 312 22,487 SH   SOLE   22,487 0 0
Verastem, Inc. Common 92337C104 11,780 1,033,324 SH   SOLE   1,033,324 0 0